Explore
Trendline
Zai Lab to Announce First Quarter 2026 Financial Results and Corporate Updates
Zai Lab to Announce First Quarter 2026 Financial Results and Corporate Updates
Read More
Trendline
Gilead Sciences to Announce Q1 2026 Financial Results with Business Update
Gilead Sciences to Announce Q1 2026 Financial Results with Business Update
Read More
Trendline
Vanda Pharmaceuticals Appoints Dr. Charles Duncan to Board, Enhancing Biotech Expertise
Vanda Pharmaceuticals Appoints Dr. Charles Duncan to Board, Enhancing Biotech Expertise
Read More
Trendline
Dover Corporation Reports Strong Q1 2026 Financial Results
Dover Corporation Reports Strong Q1 2026 Financial Results
Read More
Trendline
Clear Secure Inc. to Announce First Quarter 2026 Financial Results
Clear Secure Inc. to Announce First Quarter 2026 Financial Results
Read More
Trendline
Schrödinger to Announce First Quarter 2026 Financial Results, Impacting Investors
Schrödinger to Announce First Quarter 2026 Financial Results, Impacting Investors
Read More
Trendline
Maravai LifeSciences to Announce Q1 2026 Financial Results in Upcoming Conference Call
Maravai LifeSciences to Announce Q1 2026 Financial Results in Upcoming Conference Call
Read More
Trendline
Exelixis to Announce Q1 2026 Financial Results with Conference Call and Webcast
Exelixis to Announce Q1 2026 Financial Results with Conference Call and Webcast
Read More
Trendline
Chord Energy to Announce Q1 2026 Financial Results and Host Conference Call
Chord Energy to Announce Q1 2026 Financial Results and Host Conference Call
Read More
Trendline
Travelzoo to Host Q1 2026 Earnings Conference Call for Financial Results Discussion
Travelzoo to Host Q1 2026 Earnings Conference Call for Financial Results Discussion
Read More
Trendline
V2X, Inc. to Announce First Quarter 2026 Financial Results with Conference Call
V2X, Inc. to Announce First Quarter 2026 Financial Results with Conference Call
Read More
Trendline
AbCellera to Present Phase 1 Clinical Data for ABCL635 in Upcoming Earnings Call
AbCellera to Present Phase 1 Clinical Data for ABCL635 in Upcoming Earnings Call
Read More
